Benitec Biopharma (BNTC) Change in Account Payables: 2019-2025
Historic Change in Account Payables for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to -$5.2 million.
- Benitec Biopharma's Change in Account Payables fell 439.60% to -$5.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.4 million, marking a year-over-year decrease of 352.71%. This contributed to the annual value of -$2.4 million for FY2025, which is 352.71% down from last year.
- Per Benitec Biopharma's latest filing, its Change in Account Payables stood at -$5.2 million for Q2 2025, which was down 236.39% from $3.8 million recorded in Q1 2025.
- In the past 5 years, Benitec Biopharma's Change in Account Payables registered a high of $3.8 million during Q1 2025, and its lowest value of -$5.2 million during Q2 2025.
- For the 3-year period, Benitec Biopharma's Change in Account Payables averaged around -$3,000, with its median value being $598,000 (2023).
- In the last 5 years, Benitec Biopharma's Change in Account Payables surged by 376.95% in 2021 and then plummeted by 466.51% in 2024.
- Benitec Biopharma's Change in Account Payables (Quarterly) stood at $853,000 in 2021, then crashed by 164.48% to -$550,000 in 2022, then skyrocketed by 307.45% to $1.1 million in 2023, then plummeted by 157.67% to -$658,000 in 2024, then plummeted by 439.60% to -$5.2 million in 2025.
- Its Change in Account Payables was -$5.2 million in Q2 2025, compared to $3.8 million in Q1 2025 and -$658,000 in Q4 2024.